Center for Eating Behaviour and Metabolism Disorders, Casa di Cura San Rossore, Pisa, Italy.
Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Eat Weight Disord. 2021 May;26(4):1057-1068. doi: 10.1007/s40519-020-01015-1. Epub 2020 Sep 20.
Obesity has been proven to be a risk factor for type 2 diabetes mellitus (T2DM) through numerous pathogenetic mechanisms. Unexpectedly, some studies suggest that subjects with overweight/obesity and T2DM have better clinical outcome than their normal weight peers. This finding is described as "obesity paradox" and calls into question the importance of weight loss in this specific population.
This article is a narrative overview on the obesity and type 2 diabetes mellitus, particularly regarding the obesity paradox in T2DM patients.
We used as sources MEDLINE/PubMed, CINAHL, EMBASE, and Cochrane Library, from inception to March 2020; we chose 30 relevant papers regarding the association of obesity with clinical outcome and mortality of patients affected by T2DM.
Many studies report that in patients with T2DM, overweight and obesity are associated with a better prognosis than underweight or normal weight, suggesting the presence of an obesity paradox. However, these studies have numerous limitations due to their mainly retrospective nature and to numerous confounding factors, such as associated pathologies, antidiabetic treatments, smoking habit, lack of data about distribution of body fat or weight history.
Literature data regarding the phenomenon of obesity paradox in T2DM patients are controversial due to the several limitations of the studies; therefore in the management of patients with overweight/obesity and T2DM is recommended referring to the established guidelines, which indicate diet and physical activity as the cornerstone of the treatment.
Level V: narrative review.
大量发病机制研究表明,肥胖是 2 型糖尿病(T2DM)的危险因素。然而,一些研究表明,超重/肥胖合并 T2DM 的患者临床结局优于体重正常的患者。这种现象被称为“肥胖悖论”,这对该特定人群中减肥的重要性提出了质疑。
本文对肥胖与 2 型糖尿病,特别是肥胖悖论在 T2DM 患者中的相关问题进行了综述。
我们检索了 MEDLINE/PubMed、CINAHL、EMBASE 和 Cochrane Library 数据库,检索时间从建库至 2020 年 3 月,纳入了 30 篇关于肥胖与 T2DM 患者临床结局和死亡率关系的相关文献。
许多研究表明,在 T2DM 患者中,超重和肥胖与更好的预后相关,而体重过低或正常体重与更差的预后相关,提示存在肥胖悖论。然而,由于这些研究主要为回顾性研究,且存在多种混杂因素,如并存的疾病、降糖治疗、吸烟习惯、体脂分布或体重变化的相关数据缺乏等,因此存在诸多局限性。
由于研究的局限性,关于 T2DM 患者肥胖悖论现象的文献数据存在争议。因此,超重/肥胖合并 T2DM 患者的管理应参考既定指南,建议将饮食和运动作为治疗的基石。
V 级:综述。